Cohort information

SPAIN WP4
Organization PENTA
Name of cohort EPICO-AEP
Referring partner PENTA
Cohort Information Country(-ies), cities, regions or centers involved Spain
Time of data collection 03/2020 Ongoing
Enrolment Active
Study setting Multi-centers
Population Age Children
Type Both
Total number of patients 1340
Type of frailty (WP4)
Data collection Clinical data True
Serological data True
Genetic data False
Sample collection True
Sample collected Whole blood Yes
PBMC No
Dry-spot blood No
Plasma No
Serum No
Stool No
NP swabs No
Other None
Description In the 2 years, to determine the incidence of infection by SARS-CoV-2 in children managed in the centers associated with the research project, assessing whether it may produce seasonal outbreaks similar to those observed in infection by respiratory syncytial virus (RSV), influenza virus, or pandemics. There are also secondary studies: assessment of the influence of host genetic factors in infection by SARS-CoV-2, Assessment of the influence of host immune factors in infection by SARS-CoV-2 and comparative study of antigenic test in saliva, antigenic test in nasopharyngeal swab and RT-PCR in saliva sample versus RT-PCR in nasopharyngeal swab in pediatric population with symptoms compatible with SARS-CoV-2 infections. Vaccination (except SARS-COV-2) is included in the cohort description.